Drug Approval | June 01, 2026
Wockhardt wins FDA nod for new antibiotic ZAYNICH against drug-resistant infections
The approval marks a major milestone in the global fight against antimicrobial resistance
The approval marks a major milestone in the global fight against antimicrobial resistance
Lilly will acquire Curevo in a deal worth up to $1.5 billion in cash, including upfront and milestone-based payments.
Transition to a fermentation-based globally integrated CDMO platform
Expands manufacturing push & locks in major growth deals
The microbiology unit generated $645 million in revenue in 2025 and sits within Thermo Fisher’s Specialty Diagnostics segment
Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine
The product is manufactured at AKUMS’ state-of-the-art injectable facility in Kotdwar, Uttarakhand
His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research
Collaboration integrates SmartChip PCR technology with cloud-based analytics to enable faster, standardised monitoring of antimicrobial resistance
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
Subscribe To Our Newsletter & Stay Updated
